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Hypervariable sites in human mtDNA are readily identified in evolutionary studies and are usually assumed to
represent mutational hotspots. Recently, an alternative hypothesis was proposed that holds that hypervariable sites
may instead reflect ancient mtDNA mutations that have been “shuffled” among different lineages via recombination.
These hypotheses can be tested by examining the evolutionary rates for sites at which new mtDNA mutations are
observed; if hypervariable sites are mutational hotspots, then newly arisen mtDNA mutations should occur pref-
erentially at hypervariable sites. Results of this study show that both germline and somatic mtDNA mutations
occur preferentially at hypervariable sites, which supports the view that hypervariable sites are indeed mutational
hotspots.
The existence of hypervariable sites (sites that evolve at
a rate much faster than average) in the noncoding human
mtDNA control region has been well documented via
various analyses of humanmtDNA variation (Hasegawa
et al. 1993; Wakeley 1993; Excoffier and Yang 1999;
Meyer et al. 1999); however, it is not known why such
hypervariability exists. In the absence of any evidence,
it has been generally assumed that hypervariable sites
represent mutational hotspots, but recently it was sug-
gested that hypervariable sites may actually reflect an-
cient mutations that have been redistributed among
mtDNA lineages via recombination (Eyre-Walker et al.
1999; Hagelberg et al. 1999). Although recent claims of
recombination in human mtDNA (Awadalla et al. 1999;
Eyre-Walker et al. 1999; Hagelberg et al. 1999) have
not been substantiated in some instances (Macaulay et
al. 1999; Hagelberg et al. 2000) and remain controver-
sial (Jorde and Bamshad 2000; Kivisild and Villems
2000; Kumar et al. 2000; Parsons and Irwin 2000), the
suggestion that hypervariable sites are not mutational
hotspots deserves consideration.
One way to test this hypothesis is to examine the
evolutionary rate for sites at which new mutations have
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been observed. If hypervariable sites are indeed muta-
tional hotspots, then new mutations should occur pref-
erentially at hypervariable sites. However, if hypervari-
able sites are not mutational hotspots but, instead, reflect
recombination (or some other process), then new mu-
tations would not be expected to occur preferentially at
hypervariable sites. In this report, I analyze the evolu-
tionary rate for sites at which new mutations are ob-
served, to test the hypothesis that hypervariable sites are
mutational hotspots.
The evolutionary rate for each site in the two hyper-
variable segments (HV1 and HV2; positions 16024–
16383 and 57–372, respectively, numbered according to
the reference sequence [Anderson et al. 1981]) of the
human mtDNA control region has been estimated else-
where (Meyer et al. 1999), from patterns of variation
in worldwide populations; the overall average evolu-
tionary rate has been found to be .60 for HV1 alone
and .54 for HV1 and HV2. Two large family studies
reported a total of 12 germline mtDNA mutations for
HV1 and HV2 (Parsons et al. 1997; Sigurdardottir et
al. 2000), and the average evolutionary rate for the sites
at which these 12 mutations occurred is 2.82 (table 1),
which is 5.2 times greater than the overall average ev-
olutionary rate for HV1 and HV2. Data are also avail-
able for 12 somatic mtDNAmutations in HV1 and HV2
that were observed in tumors but not in control normal
tissues from the same individuals (Fliss et al. 2000). The
average evolutionary rate for the sites at which these 12
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Table 1
Sites in HV1 and HV2 at Which Germline, Tumor, and
Heteroplasmic Mutations Were Observed and Their Estimated
Evolutionary Rate
SITEa RATEb
NO. OF MUTATIONS
Germline Tumor Heteroplasmic
16092 .69 1 0 0
16093 2.98 2 0 13
16104 .47 0 0 2
16111 2.57 1 0 1
16124 .81 0 0 1
16129 4.78 0 0 6
16172 3.76 0 1 1
16183 3 0 1 0
16185 .61 0 0 1
16187 3.67 0 1 0
16189 4.78 0 1 3
16192 3.6 0 0 3
16205 0 0 0 1
16222 .41 0 0 1
16234 .85 0 0 1
16239 .79 0 0 2
16256 2.3 1 0 2
16257 .44 0 0 1
16262 .05 0 0 1
16265 2.18 0 1 0
16292 2.32 0 1 0
16293 3.9 0 0 3
16295 .72 0 0 1
16300 2.1 0 1 0
16301 .3 0 0 1
16309 4.03 0 0 2
16311 4.78 0 0 1
16355 2.16 0 0 1
16362 4.72 0 0 2
16380 0 0 1 0
75 0 0 1 0
94 0 1 0 0
114 .17 0 1 0
150 6.12 0 1 0
153 3.99 1 0 0
185 4.86 1 0 0
189 6.22 1 0 0
195 6.22 0 1 0
207 3.29 2 0 0
234 .69 1 0 0
Totalc 12 (2.82) 12 (2.86) 51 (2.87)
a From Comas et al. (1995); Bendall et al. (1996, 1997); Parsons
et al. (1997); Wilson et al. (1997); Hu¨hne et al. (1998); Fliss et al.
(2000); Sigurdardottir et al. (2000); Tully et al. (2000). Sites are
numbered according to the published reference sequence (Ander-
son et al. 1981).
b From Meyer et al. (1999).
c Numbers in parentheses are average rates.
tumor mutations occurred is 2.86 (table 1), which is 5.3
times greater than the overall average evolutionary rate
for HV1 and HV2. Finally, a number of studies have
documented the existence of heteroplasmy (i.e., the ex-
istence of more than one mtDNA type) for sites in the
mtDNA control region (Comas et al. 1995; Bendall et
al. 1996, 1997; Wilson et al. 1997; Hu¨hne et al. 1998;
Sigurdardottir et al. 2000; Tully et al. 2000). In principle,
the heteroplasmic state of an individual could have
arisen either via transmission from the mother (i.e.,
through the germline) or via a new somatic mutation
occurring within the individual; most of the studies that
have reported heteroplasmy have not attempted to de-
termine which mechanism might be responsible. There-
fore, for this analysis, all heteroplasmic mutations were
grouped together, resulting in data on 51 mutations
(table 1) in HV1 alone. The average evolutionary rate
for the sites at which these 51 heteroplasmic mutations
were observed is 2.87 (table 1), which is 4.8 times greater
than the overall evolutionary rate for HV1.
The distribution of inferred evolutionary rates for all
sites in HV1 and HV2 is shown in figure 1, along with
the distributions for the sites at which germline, tumor,
and heteroplasmic mtDNA mutations were reported. A
nonparametric (Mann-Whitney) test indicates that the
distribution of evolutionary rates for sites at which germ-
line, tumor, and heteroplasmic mutations were reported
are all significantly different from the distribution of ev-
olutionary rates for all sites in HV1 and HV2 (P !
for all comparisons). Thus, germline, tumor, and.001
heteroplasmic mtDNAmutations all occur preferentially
at hypervariable sites in the human mtDNA control
region.
The average evolutionary rates for sites at which germ-
line, tumor, and heteroplasmic mutations were observed
were remarkably similar (table 1). Moreover, the distri-
bution of evolutionary rates (fig. 1) does not differ
among germline, tumor, or heteroplasmic mutations
(pairwise Mann-Whitney tests; for all compar-P 1 .05
isons). This overall similarity among germline, tumor,
and heteroplasmic mutations may indicate that the un-
derlying mutational processes for mtDNA in germ cells
and in somatic cells are similar. However, it is also pos-
sible that some (or even all) of the supposed germline
mutations inferred from family studies are actually so-
matic mutations that occurred early during the prenatal
development of the individual and drifted to homoplasy
and that heteroplasmic mutations may reflect an inter-
mediate stage in this process. The observed close cor-
respondence between the evolutionary rates for somatic
mutations (both tumor and heteroplasmic) and for germ-
line mutations would then arise because the supposed
germline mutations are in fact somatic mutations. If not
all mutations observed in family studies are true germline
mutations, then this may also account for the fact that
evolutionary rates that have been determined from fam-
ily studies are higher than those inferred from evolu-
tionary studies (Parsons et al. 1997; Jazin et al. 1998;
Sigurdardottir et al. 2000). It would be of interest to
know whether individuals who exhibit what appear to
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Figure 1 Frequency distribution of inferred evolutionary rates (Meyer et al. 1999) for all sites in HV1 and HV2 and for sites at which
germline, tumor, and heteroplasmic mutations were observed.
be newly arisen, germline mtDNA mutations actually
transmit the new mutation to their offspring.
In conclusion, both somatic and (supposed) germline
mtDNA mutations occur preferentially at hypervariable
sites in HV1 and HV2. This result is not consistent with
the idea that such hypervariable sites may reflect ancient
mutations that have spread to other mtDNA lineages
via recombination (Eyre-Walker et al. 1999; Hagelberg
et al. 1999). A possible counterargument would be that
new mutations actually are rare recombination events
between paternal and maternal mtDNA. For this to be
true, however, an unusual recombination mechanism
must be postulated, because observed mutant mtDNA
types differ from the parental type almost exclusively by
single mutations, whereas paternal and maternal
mtDNA typically differ at several nucleotide positions
in the control region. Thus, any supposed mtDNA re-
combination must instead operate more like gene con-
version, involving only short stretches of mtDNA se-
quence, perhaps even single nucleotide positions. It is
difficult to imagine that such a mechanism could be op-
erating in both the germline and in somatic cells (es-
pecially tumor cells). Moreover, if recombination in-
volves only single nucleotide positions, then there is no
longer the expectation that linkage disequilibrium
should be negatively correlated with the physical dis-
tance between pairs of sites, a position still held by some
(Awadalla et al. 2000) despite criticisms concerning the
measure of linkage disequilibrium used (Jorde and Bam-
shad 2000; Kumar et al. 2000).
Given these difficulties with a recombinational mech-
anism for new mutations, it does appear that hypervar-
iable sites are hotspots for both germline and somatic
mutations. The challenge now facing mitochondrial ge-
neticists is to determine what features of these hyper-
variable sites and/or the mtDNA replication machinery
cause them to be mutational hotspots.
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